Suppr超能文献

相似文献

2
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Gene. 2015 Aug 1;567(1):1-11. doi: 10.1016/j.gene.2015.04.086. Epub 2015 May 9.
4
A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
Cancer Res. 2007 Oct 1;67(19):8975-9. doi: 10.1158/0008-5472.CAN-07-1328.
5
Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
Cancer Sci. 2011 Dec;102(12):2109-17. doi: 10.1111/j.1349-7006.2011.02066.x. Epub 2011 Sep 23.
6
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
Oncogene. 2009 Oct 15;28(41):3642-51. doi: 10.1038/onc.2009.224. Epub 2009 Aug 3.
7
Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.
Oncogene. 2010 Aug 5;29(31):4449-59. doi: 10.1038/onc.2010.185. Epub 2010 May 24.
8
NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
PLoS One. 2011;6(7):e22666. doi: 10.1371/journal.pone.0022666. Epub 2011 Jul 28.
9
Dissection of HEF1-dependent functions in motility and transcriptional regulation.
J Cell Sci. 2002 Jan 1;115(Pt 1):99-111. doi: 10.1242/jcs.115.1.99.

引用本文的文献

2
Targeting NEDD9-SH3 with a Covalent Peptide Controls Endothelial Phenotype.
bioRxiv. 2025 Jul 12:2025.07.10.663547. doi: 10.1101/2025.07.10.663547.
3
The scaffold protein CasL restrains membrane blebbing and promotes T cell migration.
J Cell Sci. 2025 Jul 15;138(14). doi: 10.1242/jcs.263792. Epub 2025 Jul 18.
5
The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241297597. doi: 10.1177/15330338241297597.
6
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.
Mol Cancer Res. 2023 Nov 1;21(11):1148-1162. doi: 10.1158/1541-7786.MCR-23-0034.
8
Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells and .
Transl Cancer Res. 2019 Sep;8(5):1873-1881. doi: 10.21037/tcr.2019.09.02.
9
NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.
J Cell Mol Med. 2021 Oct;25(19):9331-9339. doi: 10.1111/jcmm.16870. Epub 2021 Aug 25.
10
Susceptibility-Associated Genetic Variation in Contributes to Prostate Cancer Initiation and Progression.
Cancer Res. 2021 Jul 15;81(14):3766-3776. doi: 10.1158/0008-5472.CAN-20-3042. Epub 2021 Feb 25.

本文引用的文献

1
Structure and function of cas-L and integrin-mediated signaling.
Crit Rev Immunol. 2006;26(5):391-406. doi: 10.1615/critrevimmunol.v26.i5.20.
2
Differential transmission of actin motion within focal adhesions.
Science. 2007 Jan 5;315(5808):111-5. doi: 10.1126/science.1135085.
4
Force sensing by mechanical extension of the Src family kinase substrate p130Cas.
Cell. 2006 Dec 1;127(5):1015-26. doi: 10.1016/j.cell.2006.09.044.
5
Interdependence of cell attachment and cell cycle signaling.
Curr Opin Cell Biol. 2006 Oct;18(5):507-15. doi: 10.1016/j.ceb.2006.08.014. Epub 2006 Aug 17.
6
7
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.
Cell. 2006 Jun 30;125(7):1269-81. doi: 10.1016/j.cell.2006.06.008.
8
Characterization of AND-34 function and signaling.
Methods Enzymol. 2006;407:55-63. doi: 10.1016/S0076-6879(05)07006-0.
9
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors.
J Neurosci. 2006 May 3;26(18):4961-9. doi: 10.1523/JNEUROSCI.0704-06.2006.
10
Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edge.
Mol Biol Cell. 2006 Jun;17(6):2684-95. doi: 10.1091/mbc.e05-12-1161. Epub 2006 Apr 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验